This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Kevin Knopf - Innovator in Cancer Treatment
Introduction
Kevin Knopf is a notable inventor based in Kensington, Connecticut. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on the development of rhenium complexes that have potential applications in oncology.
Latest Patents
Kevin Knopf holds a patent for "Rhenium complexes and methods of use for treating cancer." This patent describes a composition that includes a rhenium ion with a +1 charge, an uncharged bidentate bicyclic ligand, and a neutral ligand selected from carbon monoxide and neutral phosphine molecules. The patent outlines methods for treating cancer by administering the described complex, showcasing his commitment to advancing medical science.
Career Highlights
Kevin Knopf is affiliated with Cornell University, where he conducts his research and collaborates with other experts in the field. His work has led to the development of innovative solutions aimed at improving cancer treatment outcomes. With a focus on practical applications, he continues to explore new avenues for research and development.
Collaborations
Some of Kevin's coworkers include Justin Wilson and Sierra C Marker. Their collaborative efforts contribute to the advancement of research in cancer treatment and the development of new therapeutic methods.
Conclusion
Kevin Knopf's contributions to cancer treatment through his patented inventions highlight the importance of innovation in medical research. His work at Cornell University and his collaboration with fellow researchers underscore the potential for advancements in oncology.